61 related articles for article (PubMed ID: 1882795)
21. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
22. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas.
Tanigawa N; Amaya H; Matsumura M; Shimomatsuya T; Horiuchi T; Muraoka R; Iki M
Cancer Res; 1996 Jun; 56(11):2671-6. PubMed ID: 8653715
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma.
Okusa Y; Ichikura T; Mochizuki H
Cancer; 1999 Mar; 85(5):1033-8. PubMed ID: 10091785
[TBL] [Abstract][Full Text] [Related]
24. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.
Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S
Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938
[TBL] [Abstract][Full Text] [Related]
25. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
26. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
27. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment for advanced carcinoma of the gastric remnant.
Isozaki H; Tanaka N; Fujii K; Nomura E; Tanigawa N
Hepatogastroenterology; 1998; 45(23):1896-900. PubMed ID: 9840172
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical study of pancreatic cystadenocarcinoma.
Motojima K; Tomioka T; Tsunoda T; Kanamatsu T
Am J Gastroenterol; 1992 Jan; 87(1):43-7. PubMed ID: 1728123
[TBL] [Abstract][Full Text] [Related]
30. Gastric cancer histology: clinicopathologic characteristics and prognostic value.
Park JM; Jang YJ; Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS
J Surg Oncol; 2008 Dec; 98(7):520-5. PubMed ID: 18802956
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma.
Maehara Y; Kakeji Y; Watanabe A; Baba H; Kusumoto H; Kohnoe S; Sugimachi K
Cancer; 1999 Jan; 85(2):302-8. PubMed ID: 10023696
[TBL] [Abstract][Full Text] [Related]
32. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
[TBL] [Abstract][Full Text] [Related]
33. [Carbohydrate antigens as a tumor-associated antigen and prognostic indicators in carcinomas of the breast, esophagus, stomach, colorectum, and pancreas].
Watanabe T; Asai H; Sakamoto J; Narita T; Ichihara T; Yamauchi M; Takagi H
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1098-101. PubMed ID: 1944163
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical studies on tumor associated carbohydrate antigens in gastric cancers of different histological stages].
Nakasaki H; Hanaue H; Miyaji M; Ogoshi K; Tajima T; Mitomi T; Hakomori S
Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1458-64. PubMed ID: 1337575
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of sialyl Tn and sialyl Lewis(a) antigens in stromal tissue correlates with peritoneal dissemination in stage IV human gastric cancer.
Ikeda Y; Mori M; Kamakura T; Saku M; Sugimachi K
Eur J Surg Oncol; 1995 Apr; 21(2):168-75. PubMed ID: 7720892
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical study of carbohydrate antigen expression in gastric carcinoma.
Dohi T; Abe K; Ohshiba S
Gastroenterol Jpn; 1989 Jun; 24(3):239-45. PubMed ID: 2663606
[TBL] [Abstract][Full Text] [Related]
37. Sialyl-Tn antigen as a useful predictor of poor prognosis in patients with advanced stomach cancer.
Terashima S; Takano Y; Ohori T; Kanno T; Kimura T; Motoki R; Kawaguchi T
Surg Today; 1998; 28(7):682-6. PubMed ID: 9697259
[TBL] [Abstract][Full Text] [Related]
38. Expression of HLA-class II antigen in gastric carcinomas. Its relationship to histopathological grade, lymphocyte infiltration and five-year survival rate.
Ma XC; Hattori T; Kushima R; Terata N; Kodama M
Acta Oncol; 1994; 33(2):187-90. PubMed ID: 8204274
[TBL] [Abstract][Full Text] [Related]
39. [Alterations of Lewis related sugar antigens in gastric atypical epithelial lesions (adenomas or dysplasia) with relation to their malignant changes--an evaluation by follow-up cases].
Horinouchi H; Sato E; Yonezawa S; Tanaka S
Nihon Shokakibyo Gakkai Zasshi; 1991 Jan; 88(1):19-27. PubMed ID: 1674009
[TBL] [Abstract][Full Text] [Related]
40. Carbohydrate antigen 19-9 in tissues and sera from patients with gastric cancer.
Maeta M; Yoshioka H; Shimizu T; Murakami A; Hamazoe R; Koga S
Oncology; 1990; 47(3):229-33. PubMed ID: 2342765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
